Cases started on MDR-TB treatment in Equatorial Guinea
Equatorial Guinea: Cases started on MDR-TB treatment was 34 in 2024. ◆ Volatile
Cases started on MDR-TB treatment in Equatorial Guinea, 2008–2024
Source: World Health Organization, Global Health Observatory.
Analysis
Equatorial Guinea recorded 34 for cases started on mdr-tb treatment in 2024.
Compared with earlier readings it is down 33.3% on the previous year and up 750.0% over ten years.
Over the whole period, cases started on mdr-tb treatment in Equatorial Guinea peaked at 54 in 2022 and was at its lowest, 0, in 2009.
That places Equatorial Guinea 98th out of 193 countries with data for 2024, putting it in the middle of the range.
The series is highly variable year to year, so single readings are best treated with caution.
Cases started on MDR-TB treatment in Equatorial Guinea, year by year
| Year | Value | Change |
|---|---|---|
| 2008 | 1 | — |
| 2009 | 0 | -100.0% |
| 2010 | 0 | — |
| 2011 | 2 | — |
| 2014 | 4 | +100.0% |
| 2015 | 26 | +550.0% |
| 2016 | 32 | +23.1% |
| 2017 | 31 | -3.1% |
| 2018 | 27 | -12.9% |
| 2019 | 39 | +44.4% |
| 2020 | 50 | +28.2% |
| 2021 | 39 | -22.0% |
| 2022 | 54 | +38.5% |
| 2023 | 51 | -5.6% |
| 2024 | 34 | -33.3% |
Equatorial Guinea compared with similar countries
- Equatorial Guinea's 34 is below the median for upper middle income countries, which is 40, 85% of the median. (57 countries reporting)
- Equatorial Guinea's 34 is below the median for Sub-Saharan Africa, which is 126.5, 27% of the median. (48 countries reporting)
Biggest year-on-year movements
Years where Cases started on MDR-TB treatment in Equatorial Guinea changed far more than this series normally does. A large move can be a real event or a change in how the figure was measured — the source note below says who published it.
| Year | Change | From | To |
|---|---|---|---|
| 2015 | +550.0% | 4 | 26 |
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2000s | 0.5 | 0 | 1 | 2 |
| 2010s | 20.12 | 0 | 39 | 8 |
| 2020s | 45.6 | 34 | 54 | 5 |
Countries ranked near Equatorial Guinea
- 96 Benin 37 compare
- 96 Mauritania 37 compare
- 99 Saudi Arabia 30 compare
- 100 Gambia 29 compare
- 101 Nicaragua 27 compare
More health data for Equatorial Guinea
- Un projection of annual infant deaths, annual growth rate -1.4 % change on previous year (2100)
- Heat deaths vs projected death rates, annual growth rate 1.06 % change on previous year (2090)
- Estimated changes in temperature-related death rates compared to projected death rates 863.6 deaths per 1,000 people (2090)
- Number of infants who die before age 1 843 deaths (2100)
- Neonatal tetanus - number of reported cases, gaps filled 5 (2025)
- Population ages 00-04, female, annual growth rate 1.5 % change on previous year (2025)
- Population ages 00-04, female, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 00-04, female, per capita 0.0663 units per person (2025)
- Population ages 00-04, male, annual growth rate 1.66 % change on previous year (2025)
- Population ages 00-04, male, per unit of GDP 0 units per US$ of GDP (2025)
Frequently asked questions
- What is cases started on mdr-tb treatment in Equatorial Guinea?
- Cases started on mdr-tb treatment in Equatorial Guinea was 34 in 2024, according to World Health Organization, Global Health Observatory.
- What is the highest cases started on mdr-tb treatment recorded in Equatorial Guinea?
- The highest recorded value was 54 in 2022.
- What is the lowest cases started on mdr-tb treatment recorded in Equatorial Guinea?
- The lowest recorded value was 0 in 2009.
- How does Equatorial Guinea rank for cases started on mdr-tb treatment?
- Equatorial Guinea ranks 98th out of 193 countries with data for 2024.
- Is cases started on mdr-tb treatment rising or falling in Equatorial Guinea?
- Over the last ten years it is up 750.0%. The long-run trend across the full record is volatile.
- Where does this Equatorial Guinea data come from?
- The figures come from World Health Organization, Global Health Observatory, published as part of Cases started on MDR-TB treatment. Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 15 observations, free to reuse under CC BY-NC-SA 3.0 IGO (WHO).